๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

19 recruiting trials

for Refractory Ewing Sarcoma

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas NCT05210374Phase 11 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma NCT06340204Phase 13 sites๐Ÿ“ Jina๐Ÿ“ Beijin๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Irinotecan Hydrochloride Liposome Injection DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma NCT06892678Phase 1, Phase 21 site๐Ÿ“ The Bronx Montefiore Medical Center ยท Tests: DFMO Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites๐Ÿ“ Baltimore๐Ÿ“ The Bronx๐Ÿ“ Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas NCT06709495Phase 1, Phase 23 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston David S Shulman, MD ยท Tests: PEEL-224, Temozolomide, Vincristine, Pegfilgrastim, Filgrastim Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Washington D.C. St. Jude Children's Research Hospital ยท Tests: Onivyde, Talazoparib, Temozolomide Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange Children's Oncology Group ยท Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors NCT02013336Phase 15 sites๐Ÿ“ Cincinnati๐Ÿ“ Oklahoma City๐Ÿ“ Dallas South Plains Oncology Consortium ยท Tests: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas NCT06465199Phase 1, Phase 214 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Hartford Milton S. Hershey Medical Center ยท Tests: Eflornithine (DFMO), AMXT 1501 Dicaprate Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) NCT07172958Phase 12 sites๐Ÿ“ Washington D.C.๐Ÿ“ Washington D.C. Children's National Research Institute ยท Tests: Selective Antigen Specific dTฮฒRII-expressing T cells combined with B7-H3 CAR T cells Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) NCT05968768Phase 22 sites๐Ÿ“ Warsaw๐Ÿ“ Wroclaw Anna Raciborska ยท Tests: Naxitamab Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330Phase 11 site๐Ÿ“ Valhalla New York Medical College ยท Tests: Vorinostat Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Miltenyi CliniMACS Prodigy ยฎ system, Zoledronic acid Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors NCT06541262Phase 1, Phase 224 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Oakland Milton S. Hershey Medical Center ยท Tests: Silmitasertib, Irinotecan, Temozolomide, Vincristine Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma NCT05734066Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C. Jazz Pharmaceuticals ยท Tests: Lurbinectedin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy